Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder

To investigate urothelial dysfunction, suburothelial inflammation, and muscarinic receptor expression in diabetic patients with overactive bladder (OAB).

[1]  C. Liao,et al.  Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity , 2014, Neurourology and urodynamics.

[2]  A. Hijaz,et al.  Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review , 2014, Current Urology Reports.

[3]  V. Petrozza,et al.  Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation , 2014, World Journal of Urology.

[4]  L. Birder,et al.  Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders , 2014, BioMed research international.

[5]  Kuo-How Huang,et al.  Hyposensitivity of C-fiber Afferents at the Distal Extremities as an Indicator of Early Stages Diabetic Bladder Dysfunction in Type 2 Diabetic Women , 2014, PloS one.

[6]  M. Michel,et al.  Does concomitant diabetes affect treatment responses in overactive bladder patients? , 2013, International journal of clinical practice.

[7]  K. Miller,et al.  Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study. , 2013, Urology.

[8]  L. Birder,et al.  Impact of diabetes mellitus on bladder uroepithelial cells. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  L. Birder,et al.  Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells , 2013, Acta physiologica.

[10]  H. Kuo,et al.  Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus , 2012, International journal of urology : official journal of the Japanese Urological Association.

[11]  Seung-June Oh,et al.  Diabetic cystopathy is associated with PARP/JNK/ mitochondrial apoptotic pathway‐mediated bladder apoptosis , 2010, Neurourology and urodynamics.

[12]  B. Howard,et al.  Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials , 2009, Diabetes Care.

[13]  E. Lukacz,et al.  Pelvic Floor Disorders, Diabetes, and Obesity in Women , 2007, Diabetes Care.

[14]  Juei-Tang Cheng,et al.  Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat. , 2007, The Journal of urology.

[15]  E. Lukacz,et al.  Pelvic Floor Disorders, Diabetes Mellitus, and Obesity in Women: Findings from the KP CARES Study , 2007 .

[16]  T. Tai,et al.  Effects of diabetes on female voiding behavior. , 2004, The Journal of urology.

[17]  E. Vittinghoff,et al.  Urinary Incontinence in Elderly Women: Findings From the Health, Aging, and Body Composition Study , 2004, Obstetrics and gynecology.

[18]  L. Birder,et al.  Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. , 2004, American journal of physiology. Renal physiology.

[19]  Juei-Tang Cheng,et al.  Alteration of M3 Subtype Muscarinic Receptors in the Diabetic Rat Urinary Bladder , 2002, Pharmacology.

[20]  Juei-Tang Cheng,et al.  Alterations in urinary bladder M2-muscarinic receptor protein and mRNA in 2-week streptozotocin-induced diabetic rats , 1999, Neuroscience Letters.

[21]  E. Kaczmarek,et al.  Techniques of image analysis for quantitative immunohistochemistry. , 2004, Roczniki Akademii Medycznej w Bialymstoku.

[22]  M. Fall,et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. , 2002, American journal of obstetrics and gynecology.